High-Dose Methotrexate Beneficial in Youth With B-ALL

This article originally appeared here.
Share this content:
High-Dose Methotrexate Beneficial in Youth With B-ALL
High-Dose Methotrexate Beneficial in Youth With B-ALL

TUESDAY, April 26, 2016 (HealthDay News) -- For children and young adults with high-risk B-acute lymphoblastic leukemia, high-dose methotrexate is associated with superior five-year event-free survival (EFS) compared with Capizzi methotrexate, according to a study published online April 25 in the Journal of Clinical Oncology.

For the study, Eric C. Larsen, M.D., from the Maine Children's Cancer Program in Scarborough, and colleagues enrolled 3,154 participants aged 1 to 30 years with newly-diagnosed high-risk B-acute lymphoblastic leukemia. A total of 2,914 patients were randomized to receive dexamethasone (14 days) or prednisone (28 days) during the induction phase and to receive high-dose methotrexate versus Capizzi escalating-dose methotrexate plus pegaspargase during interim maintenance 1.

The researchers found that high-dose methotrexate regimens were superior in planned interim monitoring, which exceeded the predefined boundary and led to cessation of enrollment. At this point, patients randomized to high-dose methotrexate during interim maintenance 1 had a five-year EFS of 82 percent, compared to 75.4 percent for those assigned to Capizzi methotrexate (P = 0.006). The mature final data five-year EFS rates were 79.6 and 75.2 percent, respectively (P = 0.008). Both marrow and central nervous system recurrences were decreased with high-dose methotrexate. A superior outcome was seen for patients aged 1 to 9 years who received dexamethasone and high-dose methotrexate versus the other three regimens (P = 0.015).

"High-dose methotrexate is superior to Capizzi methotrexate for the treatment of high-risk B-acute lymphoblastic leukemia, with no increase in acute toxicity," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Dermatography Helps Lessen Appearance of Surgical Scars

Dermatography Helps Lessen Appearance of Surgical Scars

Pigments can restore more natural skin appearance that patients are happy with

Drug-Resistant Bacteria Live in America's Water Systems

Drug-Resistant Bacteria Live in America's Water Systems

Bacteria found in plumbing may sicken thousands each year

Deep Brain Stimulation May Improve TBI Symptoms

Deep Brain Stimulation May Improve TBI Symptoms

Deep brain stimulation appears to boost function and quality of life

is free, fast, and customized just for you!

Already a member?

Sign In Now »